1
|
van der Pol CB, Sabil M, Komar M, Ruo L, Silva J, Mbuagbaw L, Liau J, Nguyen R, Chung A, Hu Z, Nanji S, Luk L, Kluger MD, Chu L, Zaheer A, Ibad HA, He J, Huang C, Le L, Hewitt B, Wang ZJ, Zins M, Rana S, Angliviel B, Depetris JN, Galgano SJ, Bolan CW, Soloff E, Arif-Tiwari H, Kambadakone A, Do RKG, Hecht EM. Factors Associated With Aborted Whipple Procedures for Periampullary Carcinoma: A Multicenter Case-Control Study by the SAR Pancreatic Ductal Adenocarcinoma Disease Focus Panel. AJR Am J Roentgenol 2025. [PMID: 40042924 DOI: 10.2214/ajr.24.32160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/27/2025]
Abstract
Background: A number of patients with periampullary carcinoma deemed resectable on preoperative CT have their curative-intent surgery aborted on the basis of intraoperative findings. Objective: This study sought to identify imaging and clinical factors associated with aborted curative-intent Whipple procedures for periampullary adenocarcinoma. Methods: Ten U.S., Canadian, and French institutions contributed data to this retrospective case-control study of 360 adults (220 men, 140 women; mean age, 68.6 ± 8.4 [SD] years) with periampullary adenocarcinoma who underwent curative-intent Whipple procedures between January 2016 and December 2022. A total of 180 patients for whom the procedure was aborted (cases) were matched by sex and 5-year age blocks with 180 patients for whom the procedure was completed (controls). Covariates included cancer type, tumor size and resectability on CT, CT reconstruction slice thickness including by phase, number of phases, multiplanar imaging, reconstruction at the workstation, possible metastases reported, structured versus unstructured report, reporting radiologist's experience, hepatic steatosis, preoperative liver MRI, endoscopic ultrasound, ERCP, multidisciplinary review, neoadjuvant therapy and response, and serum CA 19-9 and CEA levels. Logistic regression was performed with ORs and 95% CIs. Results: Whipple procedures were most frequently aborted due to metastases (67% [121/180]), followed by locally unresectable disease (28% [50/180]). Serum CA 19-9 levels of 37 U/mL or more were associated with aborted Whipple procedures with an OR of 3.75 (95% CI, 1.22-12.77) that increased to 5.47 (95% CI, 1.80-18.62) when a cutoff of 200 U/mL was applied. CT slice thickness ranged from 0.5 mm to 5 mm. CT examinations that used only slice thicknesses of 2.5 mm or more were independently associated with aborted Whipple procedures (OR = 4.28 [95% CI, 1.37-15.00]), including when assessing only pancreatic ductal adenocarcinoma. No other variables showed statistically significant association. Conclusion: Elevated serum CA 19-9 levels and preoperative CT using only slice thickness of 2.5 mm or more were associated with aborted curative-intent Whipple procedures. Many other imaging and clinical factors did not show an association. Clinical Impact: If curative-intent surgery is planned in patients with periampullary carcinoma, preoperative CT should be performed using reconstructions smaller than 2.5 mm to reduce the likelihood of incorrect staging.
Collapse
Affiliation(s)
- Christian B van der Pol
- McMaster University, 1280 Main St W, Hamilton, Ontario, Canada, L8S 4L8
- Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, 711 Concession St, Hamilton, Ontario, Canada, L8V 1C3
| | - Mustafa Sabil
- McMaster University, 1280 Main St W, Hamilton, Ontario, Canada, L8S 4L8
- Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, 711 Concession St, Hamilton, Ontario, Canada, L8V 1C3
| | - Madeline Komar
- McMaster University, 1280 Main St W, Hamilton, Ontario, Canada, L8S 4L8
| | - Leyo Ruo
- McMaster University, 1280 Main St W, Hamilton, Ontario, Canada, L8S 4L8
- Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, 711 Concession St, Hamilton, Ontario, Canada, L8V 1C3
| | - Jéssyca Silva
- McMaster University, 1280 Main St W, Hamilton, Ontario, Canada, L8S 4L8
| | - Lawrence Mbuagbaw
- McMaster University, 1280 Main St W, Hamilton, Ontario, Canada, L8S 4L8
| | - Joy Liau
- University of California, San Diego, California, USA
| | - Rina Nguyen
- University of California, San Diego, California, USA
| | | | - Zoe Hu
- Queen's University, Kingston, Ontario, Canada
| | | | - Lyndon Luk
- Columbia University Irving Medical Center, New York, New York, USA
| | - Michael D Kluger
- Columbia University Irving Medical Center, New York, New York, USA
| | - Linda Chu
- Johns Hopkins Medicine, Baltimore, Maryland, USA
| | - Atif Zaheer
- Johns Hopkins Medicine, Baltimore, Maryland, USA
| | - Hamza A Ibad
- Johns Hopkins Medicine, Baltimore, Maryland, USA
| | - Jin He
- Johns Hopkins Medicine, Baltimore, Maryland, USA
| | - Chenchan Huang
- New York University Langone Health, New York, New York, USA
| | - Linda Le
- New York University Langone Health, New York, New York, USA
| | - Brock Hewitt
- New York University Langone Health, New York, New York, USA
| | - Zhen Jane Wang
- University of California, San Francisco, California, USA
| | - Marc Zins
- Hôpital Paris Saint-Joseph, Paris, France
| | - Sumit Rana
- Hôpital Paris Saint-Joseph, Paris, France
| | | | | | | | | | - Erik Soloff
- University of Washington Medicine, Seattle, Washington, USA
| | | | | | | | | |
Collapse
|
2
|
Yasrab M, Thakker S, Wright MJ, Ahmed T, He J, Wolfgang CL, Chu LC, Weiss MJ, Kawamoto S, Johnson PT, Fishman EK, Javed AA. Factors associated with radiological misstaging of pancreatic ductal adenocarcinoma: A retrospective observational study. Curr Probl Diagn Radiol 2024; 53:458-463. [PMID: 38522966 DOI: 10.1067/j.cpradiol.2024.03.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2023] [Accepted: 03/06/2024] [Indexed: 03/26/2024]
Abstract
PURPOSE Accurate staging of disease is vital in determining appropriate care for patients with pancreatic ductal adenocarcinoma (PDAC). It has been shown that the quality of scans and the experience of a radiologist can impact computed tomography (CT) based assessment of disease. The aim of the current study was to evaluate the impact of the rereading of outside hospital (OH) CT by an expert radiologist and a repeat pancreatic protocol CT (PPCT) on staging of disease. METHODS Patients evaluated at the our institute's pancreatic multidisciplinary clinic (2006 to 2014) with OH scan and repeat PPCT performed within 30 days were included. In-house radiologists staged disease using OH scans and repeat PPCT, and factors associated with misstaging were determined. RESULTS The study included 100 patients, with a median time between OH scan and PPCT of 19 days (IQR: 13-23 days.) Stage migration was mostly accounted for by upstaging of disease (58.8 % to 83.3 %) in all comparison groups. When OH scans were rereviewed, 21.5 % of the misstaging was due to missed metastases, however, when rereads were compared to the PPCT, occult metastases accounted for the majority of misstaged patients (62.5 %). Potential factors associated with misstaging were primarily related to imaging technique. CONCLUSION A repeat PPCT results in increased detection of metastatic disease that rereviews of OH scans may otherwise miss. Accessible insurance coverage for repeat PPCT imaging even within 30 days of an OH scan could help optimize delivery of care and alleviate burdens associated with misstaging.
Collapse
Affiliation(s)
- Mohammad Yasrab
- Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Sameer Thakker
- Department of Surgery, New York University Langone Hospital, NYU Langone Health, New York City, NY, USA
| | - Michael J Wright
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Taha Ahmed
- Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Jin He
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Christopher L Wolfgang
- Department of Surgery, New York University Langone Hospital, NYU Langone Health, New York City, NY, USA
| | - Linda C Chu
- Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Matthew J Weiss
- Department of Surgery, Northwell Health, Lake Success, NY, USA
| | - Satomi Kawamoto
- Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Pamela T Johnson
- Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Elliot K Fishman
- Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Ammar A Javed
- Department of Surgery, New York University Langone Hospital, NYU Langone Health, New York City, NY, USA.
| |
Collapse
|
3
|
Badgery HE, Muhlen-Schulte T, Zalcberg JR, D'souza B, Gerstenmaier JF, Pickett C, Samra J, Croagh D. Determination of "borderline resectable" pancreatic cancer - A global assessment of 30 shades of grey. HPB (Oxford) 2023; 25:1393-1401. [PMID: 37558564 DOI: 10.1016/j.hpb.2023.07.883] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/26/2023] [Revised: 06/29/2023] [Accepted: 07/12/2023] [Indexed: 08/11/2023]
Abstract
BACKGROUND Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a poor prognosis. Accurate preoperative assessment using computed tomography (CT) to determine resectability is crucial in ensuring patients are offered the most appropriate therapeutic strategy. Despite the use of classification guidelines, any interobserver variability between reviewing surgeons and radiologists may confound decisions influencing patient treatment pathways. METHODS In this multicentre observational study, an international group of 96 clinicians (42 hepatopancreatobiliary surgeons and 54 radiologists) were surveyed and asked to report 30 pancreatic CT scans of pancreatic cancer deemed borderline at respective multidisciplinary meetings (MDM). The degree of interobserver agreement in resectability among radiologists and surgeons was assessed and subgroup regression analysis was performed. RESULTS Interobserver variability between reviewers was high with no unanimous agreement. Overall interobserver agreement was fair with a kappa value of 0.32 with a higher rate of agreement among radiologists over surgeons. CONCLUSION Interobserver variability among radiologists and surgeons globally is high, calling into question the consistency of clinical decision making for patients with PDAC and suggesting that central review may be required for studies of neoadjuvant or adjuvant approaches in future as well as ongoing quality control initiatives, even amongst experts in the field.
Collapse
Affiliation(s)
- Henry E Badgery
- Department of Upper Gastrointestinal Surgery, St Vincent's Hospital Melbourne, Melbourne, Australia; Department of Surgery, The University of Melbourne, St Vincent's Hospital, Melbourne, Australia
| | - Tjuntu Muhlen-Schulte
- Cancer Research Program, School of Public Health & Preventive Medicine Monash University, Melbourne, Australia
| | - John R Zalcberg
- Cancer Research Program, School of Public Health & Preventive Medicine Monash University, Melbourne, Australia; Department of Oncology, Alfred Health, Melbourne, Victoria, Australia
| | - Bianka D'souza
- Cancer Research Program, School of Public Health & Preventive Medicine Monash University, Melbourne, Australia
| | | | - Craig Pickett
- Department of Epidemiology and Preventive Medicine, School of Public Health & Preventive Medicine Monash University, Melbourne, Australia; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia
| | - Jaswinder Samra
- Department of Upper GI Surgery, Royal North Shore Hospital, NSW, Australia
| | - Daniel Croagh
- Department of Upper Gastrointestinal Surgery, St Vincent's Hospital Melbourne, Melbourne, Australia; Department of Surgery, Monash University, Melbourne, Victoria, Australia; Monash Health, Melbourne, Victoria, Australia.
| |
Collapse
|